Your browser doesn't support javascript.
loading
Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial.
Grignani, Giovanni; Palmerini, Emanuela; Ferraresi, Virginia; D'Ambrosio, Lorenzo; Bertulli, Rossella; Asaftei, Sebastian Dorin; Tamburini, Angela; Pignochino, Ymera; Sangiolo, Dario; Marchesi, Emanuela; Capozzi, Federica; Biagini, Roberto; Gambarotti, Marco; Fagioli, Franca; Casali, Paolo Giovanni; Picci, Piero; Ferrari, Stefano; Aglietta, Massimo.
Afiliação
  • Grignani G; Medical Oncology, Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy. Electronic address: giovanni.grignani@ircc.it.
  • Palmerini E; Chemotherapy, Musculoskeletal Oncology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
  • Ferraresi V; Medical Oncology A, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • D'Ambrosio L; Medical Oncology, Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy; Department of Oncology, University of Torino, Turin, Italy.
  • Bertulli R; Adult Mesenchymal Tumor Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Asaftei SD; Pediatric Onco-Hematology, Città della Salute e della Scienza di Torino, Turin, Italy.
  • Tamburini A; Paediatric Onco-Hematology, Azienda Ospedaliero Universitaria Meyer Children Hospital, Firenze, Italy.
  • Pignochino Y; Medical Oncology, Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy; Department of Oncology, University of Torino, Turin, Italy.
  • Sangiolo D; Medical Oncology, Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy; Department of Oncology, University of Torino, Turin, Italy.
  • Marchesi E; Chemotherapy, Musculoskeletal Oncology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
  • Capozzi F; Medical Oncology, Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy; Department of Oncology, University of Torino, Turin, Italy.
  • Biagini R; Oncological Orthopaedics Department, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Gambarotti M; Department of Pathology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
  • Fagioli F; Pediatric Onco-Hematology, Città della Salute e della Scienza di Torino, Turin, Italy.
  • Casali PG; Adult Mesenchymal Tumor Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Picci P; Laboratory of Experimental Oncology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
  • Ferrari S; Chemotherapy, Musculoskeletal Oncology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
  • Aglietta M; Medical Oncology, Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy; Department of Oncology, University of Torino, Turin, Italy.
Lancet Oncol ; 16(1): 98-107, 2015 Jan.
Article em En | MEDLINE | ID: mdl-25498219
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas / Aromoterapia Assunto principal: Neoplasias Ósseas / Protocolos de Quimioterapia Combinada Antineoplásica / Osteossarcoma / Serina-Treonina Quinases TOR Tipo de estudo: Clinical_trials País/Região como assunto: Europa Idioma: En Revista: Lancet Oncol Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas / Aromoterapia Assunto principal: Neoplasias Ósseas / Protocolos de Quimioterapia Combinada Antineoplásica / Osteossarcoma / Serina-Treonina Quinases TOR Tipo de estudo: Clinical_trials País/Região como assunto: Europa Idioma: En Revista: Lancet Oncol Ano de publicação: 2015 Tipo de documento: Article